节点文献
沙蚕蛋白酶及同工酶的分离纯化、性质及药用生物活性研究
Purification, Characterization and Pharmacodynamic Activity of Proteases and Its Isoenzyme from Nereis Virens
【作者】 李奇;
【导师】 洪敏;
【作者基本信息】 吉林大学 , 生物化学与分子生物学, 2008, 博士
【摘要】 本论文报告了沙蚕蛋白酶及其同工酶的分离纯化工艺,生物化学特征、酶学性质、药用生物活性。应用硫酸铵盐析、凝胶过滤层析、疏水层析等技术从沙蚕体内分离得到沙蚕蛋白酶。通过聚丙烯酰胺凝胶电泳、高效液相色谱、等电聚焦电泳和质谱分析、肽指纹图谱分析、氨基酸序列分析及酶学性质、免疫原性等实验证实:沙蚕蛋白酶是一组蛋白酶,该酶由三个组分组成,均为序列未知的新蛋白质,均有纤溶活性;其中两个组分具有高度同源性,结构相似,功能、抗原性、酶学性质基本相同;另一个组分与二者功能相同、酶学性质相似,结构不同、抗原性与二者不同。它们是一组同工酶,属于丝氨酸蛋白酶类;既有纤溶酶活性又有激酶活性,以直接纤溶酶活性为主;均为酸性蛋白质。通过纤维蛋白原(Fg)、D-二聚体(D-Dimer)含量、血浆优球蛋白溶解时间(ELT)测定,凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)测定;通过二磷酸腺苷(ADP)、花生四烯酸(AA)及胶原(CG)诱导血小板聚集,测定血小板最大聚集率;建立静脉高分子右旋糖酐高粘滞血症模型,检测血液流变学指标;应用体内、外血栓形成等实验,研究结果证明:沙蚕蛋白酶具有很强的纤维蛋白原及纤维蛋白溶解活性;对凝血功能未见有影响;有显著的抑制血小板聚集作用;有显著改善血液流变学作用;有抗血栓形成作用。本文研究内容和理论成果丰富、创新性鲜明,潜在应用性很大,为蛋白酶类降纤、溶栓新药研究奠定了坚实基础。
【Abstract】 Nereis virens (N-V) protease, a kind of proteolytic enzyme in Nereis succinea, had been extracted successfully in our laboratory. N-V protease is able to hydrolyze fibrinogen and fibrin significantly both in vivo and in vitro which can be developed a de-fibrin & thrombolytic drug and can be utilized in clinic as a therapeutic approach for heart and brain infarction, for treating and preventing heart and brain thrombus diseases. We have claimed patent for this protease with the application number 02144828.0, and patent number 1500873. We have also submitted it to Swiss protein with the ID P83433. It was found in our research that N-V proteases are a group of isoenzymes which mean they share same function, similar properties of enzymology and cross-reacting antigen determinant but have structure difference. They possess the pharmacodynamic avtivities to lower the fibrin, to counteract platelet aggregation, to amendment hemorrheology and to dissolve thrombus which makes it possible to be developed into a new thrombolytic drug. The study is not only a rational research but also an application research; some advanced techniques and methods are applied in this study. We studied isolation and purification process of the N-V protease; its biochemistry characteristics and pharmacodynamic avtivities. The first part is the study on purification of N-V Protease. Ammonium sulfate salting-out, Sephacryl gel filtration chromatography (GFC) and hydrophobic chromatography of phenyl Sepharose techniques were used to separate and purify the N-V protease; optimized salting-out and chromatography experimental conditions were reported in this part. Polyacrylamide gel electrophoresis (PAGE) was adopted to purify the enzyme; dialysis and Sephadex G-25 gel filtration techniques were used to desalt; ultrafiltration and Sephacryl S-200 GFC were used to remove pyretogen; bacterial endotoxin detection and rabbit were used to test pyretogen. In order to search for a better freeze-dry technique, we compared two pre-freeze methods: quick freezing and slow freezing, and analysised the temperature of sublimation and the time of resolution to map freeze drying curve. Fibrin plate method was used to detect Neresis protease fibrinolytic activity in vitro, and ultraviolet absorption & Bradford methods were applied in order to definite the content of protein.The second part of this paper is the study on characterization of N-V protease and its isoenzymes. The purity of N-V protease was identified by PAGE, immobilized pH gradient isoelectric electrophoresis (IPGIEF) and gel filtration high performance liquid chromatography (HPLC) ; relative molecular weight was determined by using high-performance liquid chromatography - mass spectrometry (LC / MS) and structure was analysised by detecting the peptide mass fingerprint (PMF) with MALDI-TOF-MS mass spectrometer; Amino acid sequence was preliminarily definited by N-terminus analysis of amino acid sequence; polyclonal antibody was harvested from immunifaction rabbit, antibody titer and antigenicity was determined by antigen-antibody reaction; the optimum reaction temperature and pH were definited by fibrin plate, and four kinds of specific protease inhibitors were used in order to determine classification of N-V protease. Fibrin plate which contain agarose as supporting dielectric with and without plasminogen were used to analysis its fibrinoclase and kinase activities.The third part of this paper is the study on pharmacodynamic avtivity of N-V protease. Fibrin plate was adopted to assess valence and the fibrinolytic bioactivity of N-V protease in vitro. The fibrin plate method was used in order to assess N-V protease activity on hydrolyzing fibrin in vitro; the content of Fg and D-Dimer, ELT were assayed to study the effect of N-V protease on fibrinolysis in normal rabbits; PT, APTT were measured to observe the effect of N-V protease on blood coagulation function. Adenosine diphosphate (ADP), arachidonic acid (AA) and collagen (CG) were used to induce platelet aggregation in rats and the maximum ratio of platelet aggregation was detected.The hemorheological effect was observed by building the model of hyperviscosity blood syndrome in rats with high molecular dextran. The effects on antithrombus formation were observed by thrombosis experiment of rats and rabbits in vivo and in vitro.The experimental results are as follows:1. Purification of the N-V protease.By the methods we used to purify the N-V protease, the protein concentration and fibrinolytic activity in raw material of Nereis succinea, fractions from ammonium sulfate salting-out, Sephacryl gel filtration and phenyl chromatography showed that the recovery of N-V protease reached 75% and the specific activity was increase by 60-fold. Five different pre-installed chromatographic columns were used to choose hydrophobic medium. By analysising PAGE results and assaying content and activity, it showed that Phenyl Sepharose HS is the best purification media. By optimizing the elution conditions, it was showed that the optimal concentration of ammonium sulfate was 1.5mol·L-1.By comparing desalting methods, dialysis and Sephadex G-25 gel filtration chromatography , the latter was the final choice because it could deal with large samples and be monitored easily; By comparing the ultrafiltration and Sephacryl S-200 gel filtration chromatography to remove the pyretogen, ultrafiltration membrane with the molecular weight of 100kD was chose. pyrogen was detected by bacterial endotoxin test and poyrogen test, pyrogen test is a standard method, and it is generally considered that negative bacterial endotoxin test result was valid, positive bacterial endotoxin test result needs to be rechecked by pyrogen test, those with negative results in pyrogen test could be administrated clinically. Slow freezing method was optimal, sublimation temperature was–5℃and the time of resolution was 4 hours.2. characterization of the N-V protease and its Isoenzymes.Three strips were showed clearly on polyacrylamide gel. Among them, stripⅡwas found to be the major product (50%) , StripⅠandⅢwere minor band (30% and 20% respectively) by the analysis of the density scan. The isoelectric focus electrophoresis showed three strips, which exhibited the isoelectric point of the N-V protease point at 3.5 -4.5. No significant change of isoelectric point was observed among three components. HPLC analysis of the N-V protease revealed three major peaks. The total integrated area was 95.24%. Three fractions were collected and their activities were examined. The results showed that all of them possessed fibrinolytic activity. Purity of the N-V protease reached 95% by HPLC analysis, which was consistent to PAGE results. The molecular weight of three compositions was 29248.75D, 29007.66D, and 28954.17D, determined by mass spectrum (MS). The PMF confirmed that the three compositions were new proteins without having been known the sequences. The structure of two of them (componentSⅡ、Ⅲ) was resemble and had high homology, and the other was different in peptide finger printing map. ComponentsⅡ、Ⅲhave identical immunogenicity, the other is different from them. But three compositions have identical antigen determinant group which was proved by antigen-antibody reactions. Results of the analysis of the amino acids sequences for the ten peptide sections are as follows: NVVAVK, INL, QAPNYSTASY, FLSTNNK, LYIHDTGVR, AVYLAGMK, NFPNYYINLY, VYLAANPTASS, QTFNSDTL, VYILDTGI, it is suggested that the N-V protease is new protease by alignment of amino acid sequence, this conclusion is uniform with PMF. The N-V protease is a kind of serine proteinase according to the analysis of the amino acid sequence and enzyme inhibitor experiments. It possess both fibrinoclase and kinase activity, but the main function is direct fibrinolysis. The optimal temperature of the protease is 50℃, the optimal pH is 8-9.The enzymology properties of three components of N-V protease are similar. ComponentⅠshares same function, similar enzymology properties, homology and variability in structure, and has different antigenicity with componentsⅡ、Ⅲ, which indicates they are isoenzymes.3. Pharmacodynamic avtivity of the N-V protease N-V protease possessed the fibrinolytic activity in vitro and vivo proved by its function of decreasing the content of Fg, D-Dimer and shortening ELT without influence on the APTT, PT, and the effects on blood coagulation function are not observed. It was found that N-V protease inhibited platelet aggregation with different revulsant in rats and reduced the maximum aggregation rate; N-V protease reduced whole blood viscosity, and had no effects on plasma viscosity, blood sedimentation rate, and volume of packed red cells in rats; N-V protease could effectually inhibit the thrombogensis of rats in body and in vitro, the thrombogensis of rabbits in vitro. N-V protease possesses strong effect against platelet aggregation, improves hemorheological characteristics, and exerts remarkable effect against thrombosis.
【Key words】 nereis virens protease; isoenzyme; purification; characterization; immobilized pH gradient isoelectric electrophoresis (IPGIEF); HPLC; mass spectrum; peptide finger printing (PMF); analysis of amino acid sequence; antigenicity; fibrinolytic activity; coagulation function; thrombosis; platelet aggregation; hemorheology;